American Express enters the week with an unusual split: options traders are the most bullish they've been all year, yet most of the Street spent the past fortnight cutting price targets.
The clearest signal is in options. Call demand has overtaken puts more decisively than usual — the put/call ratio has dropped to 0.65, well below its 20-day average of 0.71 and 1.6 standard deviations beneath that mean. That's the most call-heavy reading of the past year, with the 52-week low at 0.45 the only period more bullish. The move is notable because it runs against the grain of a stock that has drifted 1.7% lower on the week and nearly 3% lower over the past month, closing at $340.81.
The lending market, by contrast, tells a completely unexciting story. Borrow availability is essentially unlimited — more than 497 million shares remain available for borrowing, a figure so large it reads as uncapped in the data. Short interest is just 1.7% of the free float, barely changed week-on-week, and cost to borrow has collapsed 44% over the past seven days to 0.34%. None of that points to meaningful short conviction. COF and SYF, the two closest peers by correlation, both fell on the week as well — COF down 1.2% and SYF off 0.8% — so the week's softness in AXP looks like a sector-wide drift rather than stock-specific pressure.
The Street has been quietly trimming targets since the July 24 earnings print. Morgan Stanley maintained Equal-Weight but nudged its target down to $382 from $385. Evercore ISI held In-Line but cut to $370 from $380. BTIG, already at Sell, lowered to $315. The direction of travel was clearly cautious. But this week's note from Piper Sandler pushed the other way — maintaining Overweight and lifting the target to $405 from $396, suggesting at least one firm read the post-earnings dip as an opportunity. The consensus sits at Buy with a mean target of $375.86, implying roughly 10% return potential from current levels. The valuation tells a similar story: the trailing P/E has eased to 17.8x, down nearly a full point over the past month, while the price-to-book of 6.1x has also softened — multiples contracting on a flat-to-lower stock, not on earnings downgrades.
The bull and bear cases are well defined. Bulls point to new account growth in both Consumer and Commercial segments as a structural offset to slower same-customer spending, and argue that a growing base of fee-paying cardholders is a durable revenue engine. Bears counter that new card acquisition fell both quarter-over-quarter and year-over-year at the last print, and that the Platinum Card refresh may have masked weakening underlying trends — with revenue growth potentially stalling at 5-8% on an organic basis. The dividend factor score ranks in the 94th percentile, reflecting the strength of AXP's capital return history, though the dividend data available is dated and not a current catalyst.
Berkshire Hathaway's 22.5% anchor stake remains the gravitational centre of the ownership story, unchanged as of the last filing. The ORTEX short score has drifted incrementally higher through August, reaching 34.7 — up from roughly 34.3 at the start of the month — but remains firmly in low-conviction territory. The next earnings date is October 23, leaving more than two months for the Street debate on new card trends versus fee-base growth to play out. The immediate question is whether the unusual call-side enthusiasm in options — arriving just as most analysts were trimming — reflects genuine conviction, or simply positioning ahead of a potential re-rating.
See the live data behind this article on ORTEX.
Open AXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
